Abstract
The Massachusetts Department of Public Health, with the assistance of the Centers for Disease Control, conducted a study to determine the prevalence of elevated levels (> 30 ng ml −1) of polychlorinated biphenyls (PCBs) in serum taken from residents of the greater New Bedford area in Massachusetts. The criteria and procedures used to establish interlaboratory comparability for measurements for PCBs in human serum, the establishment and performance of the quality control system and the comparability of results on human serum samples from the New Bedford study are described. Aspects of interlaboratory comparability addressed include the establishment of common extraction and analytical methods, joint analyses of bovine serum pools (both in vitro-spiked pools and in vivo pools from a cow that was fed PCBs), establishment of quality control charts and rules for acceptability of analytical runs and joint analyses of a subset ( n = 207) of the human serum samples from the New Bedford study. The 207 jointly analyzed samples had PCB levels that ranged from 1 to 214 ng ml −1 and had an interlaboratory correlation coefficient of 0.96.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
